Monoclonal antibody Adnab-9 defines a preneoplastic marker in epithelium at risk for adenocarcinoma of the small intestine

Human Pathology

Volumn 30, Issue 4, 1999, Pages 467-473

  Tobi, Martin ^a   Kaila, Vijiya ^b   Hassan, Nadeem ^b   Gallinger, Steven ^b   Fligiel, Suzanne ^b   Hatfield, James ^b   Gesell, Mark ^b   Sakr, Wael ^b   Luk, Gordon ^b   Odze, Robert D ^b  

^a HARPER UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

Adenoma; Monoclonal antibodies; Paneth cells; Small bowel carcinoma

Indexed keywords

MONOCLONAL ANTIBODY;

ADENOCARCINOMA; ADENOMATOUS POLYP; ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INTESTINE EPITHELIUM; MALE; PRECANCER; RISK ASSESSMENT; SMALL INTESTINE CARCINOMA;

EID: 13044266354     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0046-8177(99)90124-7     Document Type: Article

References (32)

1. Hill MJ, Morson BC, Bussey HJR: Aetiology of adenocarcinoma sequence in large bowel. Lancet 1:215-217, 1978
2. Muto T, Bussey HJR, Morson BC: The evolution of cancer of the colon and rectum. Cancer 36:2251-2270, 1975
3. Fenoglio CM, Kaye GI, Pascal RR, et al: Defining the precursor tissue of ordinary large bowel carcinoma: Implications for cancer prevention. Pathol Annu 12:87-116, 1977
4. Boland CR, Itzkowitz SH, Kim VS: Colonic polyps and the gastrointestinal polyposis syndrome, in Sleisenger MH, Fordtran JS (eds): Gastrointestinal Disease: Pathophysiology, Diagnosis, Management, vol 80 (ed 3). Philadelphia, PA, Saunders, 1989, pp 1483-1518
5. Sellner F: Investigations on the significance of the adenoma-carcinoma sequence in the small bowel. Cancer 66:702-715, 1990
6. Neugut AI, Santos J: The association between cancer of the large and small bowel. Cancer Epidemiol Biomarkers Prev 2:551-553, 1993
7. Silverberg E, Lubera J: Cancer statistics 1988. CA 38:16-17, 1988
8. Severson RK, Schenk M, Gurney JG, et al: Increasing incidence of adenocarcinomas and carcinoid tumors of the small intestine in adults. Cancer Epidemiol Biomarkers Prev 5:81-84, 1996
9. Lance P: Tumors and other neoplastic diseases of the small intestine, in Yamada T, Alpers DM, Owyang C, et al (eds): Textbook of Gastroenterology, vol 2 (ed 1). Philadelphia, PA, Lippincott, 1991, pp 1485-1503
10. Zollinger RM, Steinfeld WC, Schreiber H: Primary neoplasm of the small intestine. Am J Surg 151:654-658, 1986
11. Frost DB, Mercado PD: Small bowel cancer: A 30-year review. Ann Surg Oncol 1:290-295, 1994
12. DiSario JA, Burt RW, Varyas H, et al: Small bowel cancer: Epidemiological and clinical characteristics from a population-based registry. Am J Gastroenterol 89:699-701, 1994
13. Tobi M, Maliakkal BJ, Alousi MA, et al: Cellular distribution of a colonic adenoma-associated antigen as defined by monoclonal antibody Adnab-9. Scand J Gastroenterol 27:737-742, 1992
14. Tobi M, Cats A, Maliakkal B, et al: Zollinger Ellison Syndrome [ZES], acromegaly and colorectal neoplasia: J Clin Gastroenterol 24:21-24, 1997
15. Tobi M, Kaila V, Goo R, et al: An adenoma-associated antigen as a precolonoscopic marker in familial polyposis coli versus sporadic colonic neoplasia. Gastroenterology 102:A403, 1992
16. Quaroni A, Weiser MM, Herrera L, et al: Crypt cell antigens [CCA]: New carbohydrate markers for human colon cancer cells. Immunol Invest 18:391-404, 1989
17. Riddell RH: Premalignant and early malignant lesions in the gastrointestinal tract: Definitions, terminology, and problems. Am J Gastroenterol 91:864-872, 1996
18. Hsu SM, Raine L, Fanger V: Use of avidin-biotin-peroxidase complex [ABC] in immunoperoxidase techniques: A comparison between ABC and unlabelled antibody [PA] procedures. J Histochem 21:577-580, 1981
19. Fearon ER, Vogelstein B: A genetic model of colorectal tumorgenesis. Cell 61:759-767, 1990
20. Tobi M, Elitsur Y, Moyer MP, et al: Mucosal origin and shedding of an early colonic tumor marker defined by Adnab-9 monoclonal antibody. Scand J Gastroenterol 28:1025-1034, 1993
21. Quaroni A, Weiser MM, Lee S, et al: Expression of developmentally regulated crypt cell antigens in human and rat intestinal tumors. J Natl Cancer Inst 77:405-415, 1986
22. Lien GS, Mori M, Enjoi M: Primary carcinoma of the small intestine: A clinicopathologic and immunohistochemical study. Cancer 61:316-323, 1988
23. Jones DE, Bevins CL: Paneth cells of the human small intestine express an antimicrobial peptide gene. J Biol Chem 267: 23216-23225, 1992
24. Quellete AJ: Paneth cells and innate immunity in the crypt microenvironment. Gastroenterology 113:1779-1784, 1997
25. Odze R: Epithelial proliferation and differentiation in flat duodenal mucosa of patients with familial adenomatous polyposis. Mod Pathol 8:648-653, 1995
26. Bulow S, Skov Olsen P, Poulsen SS, et al: Is epidermal growth factor involved in development of duodenal polyps in familial polyposis coli. Am J Gastroenterol 83:404-406, 1988
27. Symonds DA: Paneth cell metaplasia in diseases of the colon and rectum. Arch Pathol 97:343-347, 1974
28. Dick W, Schwandner G: Klinische bedeuting des lysozyms bei kolorektalen tumoren. Munch Med Wochenschr 124:619-620, 1982
29. Costongs GM, Hemrika MH, Engels LG, et al: Faecal lysozyme determination, reference intervals and some data in gastrointestinal disease. Clin Chim Acta 167:125-134, 1987
30. Rubio CA: Paneth cell adenoma of the stomach. Am J Surg Pathol 13:325-328, 1989
31. Holmes EJ: Neoplastic Paneth cells: Their occurrences in two adenomas and one carcinoma of the colon. Cancer 18:1416-1422, 1965
32. Odze R, Gallinger S, So K, et al: Duodenal adenomas in familial adenomatous polyposis: Relation of cell differentiation and mucin histochemical features to growth pattern. Mod Pathol 7:376-384, 1994